Patent Law Weblog
recent posts
- Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc. (2026)
- Constellation Designs, LLC v. LG Electronics Inc. (Fed. Cir. 2026)
- Actelion Pharmaceuticals Ltd. v. Mylan Pharmaceuticals Inc. (Fed. Cir. 2026)
- PTAB Reverses § 101 Rejection Where Examiner Failed to Follow the Office’s Own Guidance
- Collision Communications v. Samsung: What Good Did the Government’s Statement of Interest Do?
about
Month: April 2009
-
By Suresh Pillai — AstraZeneca Secures Temporary Restraining Order in PULMICORT® Case Last week, the U.S. District Court for the District of New Jersey barred Apotex from launching a generic version of PULMICORT® by granting AstraZeneca's requested temporary restraining order (see "Biotech/Pharma Docket," April 15, 2009). The TRO will remain in effect at least…
-
Another "Bright-Line" Rule from the Federal Circuit By Kevin E. Noonan — The Supreme Court has had the occasion to overrule the Federal Circuit with prolixity over the past ten years. And in many of those cases (including KSR Int’l Co. v. Teleflex Inc., eBay Inc. v. MercExchange, LLC, Quanta Computer, Inc. v. LG…
-
By Sherri Oslick — About Court Report: Each week we will report briefly on recently filed biotech and pharma cases, and a few interesting cases will be selected for periodic monitoring. Par Pharmaceutical, Inc. v. Novartis Pharmaceuticals Corp. et al.2:09-cv-01592; filed April 16, 2009 in the Eastern District of Pennsylvania Declaratory judgment of…
-
April 20-21, 2009 – 5th International Judges Conference on Intellectual Property Law (Intellectual Property Owners Association) – Washington, DC April 20-21, 2009 – 6th Annual Freedom to Operate Forum (C5 (UK)) – London, England April 22, 2009 – "How Recent Patent Developments May Be Creating a 'Perfect Storm' for Biotechnology" (Association of Patent Law Firms)…
-
The Association of Patent Law Firms (APLF) will be offering a dial in presentation entitled: "How Recent Patent Developments May Be Creating a 'Perfect Storm' for Biotechnology" on April 22, 2009 from 12:30-1:30 PM (EST). Kevin Noonan, Andrew Williams, and Donald Zuhn of McDonnell Boehnen Hulbert and Berghoff LLP will discuss recent decisions on obviousness…
-
Intellectual Asset Management (IAM) magazine will be hosting the second IP Business Congress on June 21-23, 2009 in Chicago, IL. The IP Business Congress is designed to meet the needs of senior business executives responsible for the creation and management of IP value inside corporations, as well as those who advise them. Among the plenary…
-
Law Seminars International (LSI) will be holding a one-day workshop on Patent Enforcement & Early Stage Litigation on June 19, 2009 in San Francisco, CA. During the workshop, LSI's faculty will offer presentations on the following topics: • Recent decisions impacting patent viability, value, and enforceability;• A fresh look at the plaintiff's decision to sue…
-
By Donald Zuhn — At last month's Biotechnology Industry Organization (BIO) Intellectual Property Counsels' Committee (IPCC) conference, Q. Todd Dickinson, Executive Director of the American Intellectual Property Law Association (AIPLA), and E. Anthony Figg of Rothwell, Figg, Ernst & Manbeck, P.C. provided an update on the status of patent reform legislation in one of…
-
By Christopher P. Singer — In a Notice, dated April 13, 2009, the U.S. Patent and Trademark Office announced that it will continue the existing Patent Prosecution Highway (PPH) Pilot Program with the Intellectual Property Office of Australia (IP Australia) for an unspecified period of time in order to gather more information and assess…
-
By Suresh Pillai — Resolution Announced in Johnson & Johnson Razadyne® ER Patent Litigation Johnson & Johnson units Janssen LP, Janssen Pharmaceutica NV, and Ortho-McNeil Neurologics have stipulated to a dismissal with prejudice of all claims of patent infringement against KV Pharmaceutical Co., Barr Pharmaceuticals Inc., and Sandoz Inc. with respect to a generic…
Patent Docs 